Shareholders’ Equity |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| Shareholders’ Equity | Note 8 - Shareholders’ Equity
The Company is authorized to issue shares of common stock, with a par value of $ per share. As of December 31, 2025, and 2024, there were shares of common stock issued and outstanding.
On October 7, 2025, Exworth Management LLC forgave the outstanding loan balance of $103,321 which was deemed as a capital contribution.
On December 31, 2025, John P. O’Shea and Yuanyuan Huang forgave outstanding consulting fees of $2,500 and $7,500, respectively. In addition, OTC-related expenses of $11,000 paid on behalf of the Company by Exworth Management were also forgiven. The forgiveness of these amounts has been accounted for as a capital contributions and recorded within additional paid-in capital.
On October 31, 2024, the Company’s Board of Directors approved and adopted an amendment and restatement of the Company’s bylaws (the “Amended and Restated Bylaws”), effective November 1, 2024. Among other provisions, the Amended and Restated Bylaws authorize the issuance of uncertificated shares for some or all classes or series of the Company’s capital stock.
For additional share issuances subsequent to year-end, see “Note 12 – Subsequent Events”.
|